Diagnostic testing for syphilis.

Fisher Scientific has been awarded a Texas state and local contract (ID: 0000415780) effective September 30, 2026, for the provision of diagnostic testing services and reagents for syphilis. The contract encompasses a comprehensive range of clinical laboratory supplies and materials, including clinical chemistry reagents, deoxyribonucleic acid (DNA) sequence analyzer reagents, flame photometer analyzer reagents or kits, nucleic acid extraction isolation and purification analyzer reagents and kits, and alkaline phosphatase supplies. These materials are classified under the North American Industry Classification System commodity codes for diagnostic reagents and supplies used in automated chemistry applications.

The specific financial terms, including annual value, total contract amount, and cumulative value, were not provided in the available documentation. Similarly, the identity of the specific Texas government entity awarding the contract, the designated place of performance, and the contract performance period beyond the award date could not be determined from the materials provided. As the prime contractor, Fisher Scientific will be responsible for delivering the reagents and diagnostic supplies necessary to support syphilis testing programs within the State of Texas.